Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2010 by University Hospital, Bonn.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Dr. Axel Baumgarten, Berlin
Dr. Christoph Stephan, Frankfurt/M
Dr. Stefan Esser, Essen
Dr. Keikawus Arastéh, Berlin
Prof. Dr. Hans-Jürgen Stellbrink, Hamburg
Dr. Thomas Lutz, Frankfurt/M
Dr. Jörg Gölz , Berlin
Information provided by:
University Hospital, Bonn
ClinicalTrials.gov Identifier:
NCT01225705
First received: October 20, 2010
Last updated: NA
Last verified: October 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given